AUTODELFIA HAFP TEST KIT

Kit, Test, Alpha-fetoprotein For Neural Tube Defects

FDA Premarket Approval P970037

This medical device has supplements. The device description/function or indication may have changed. Be sure to look at the supplements to get an up-to-date information on device changes. The labeling included below is the version at time of approval of the original pma or panel track supplement and may not represent the most recent labeling.

Pre-market Approval Supplement Details

The device is intended for the quantitative determination of human alpha-fetoprotein (afp) in maternal serum and amniotic fluid obtained between the 15th and 21st weeks of gestation. The assay is to be peformed on the 1235 autodelfia(tm) automatic immunoassay system, and is intended for use only in conjunction with other diagnostic tools such as ultrasound and amniography as an aid in the detection of open neural tube defects (ontds).

DeviceAUTODELFIA HAFP TEST KIT
Classification NameKit, Test, Alpha-fetoprotein For Neural Tube Defects
Generic NameKit, Test, Alpha-fetoprotein For Neural Tube Defects
ApplicantPerkinElmer, Inc.
Date Received1997-08-26
Decision Date1998-03-31
Notice Date1998-05-27
PMAP970037
SupplementS
Product CodeLOK
Docket Number98M-0306
Advisory CommitteeImmunology
Expedited ReviewNo
Combination Product No
Applicant Address PerkinElmer, Inc. 940 Winter Street waltham, MA 02451

Supplemental Filings

Supplement NumberDateSupplement Type
P970037Original Filing
S012 2021-07-15 30-day Notice
S011 2018-08-09 30-day Notice
S010 2017-05-11 30-day Notice
S009 2016-07-27 30-day Notice
S008 2012-05-15 30-day Notice
S007 2011-09-23 135 Review Track For 30-day Notice
S006 2011-06-13 30-day Notice
S005 2011-03-17 30-day Notice
S004 2011-02-02 30-day Notice
S003 2010-03-01 Normal 180 Day Track
S002 2008-09-17 Normal 180 Day Track
S001 2002-10-18 Special (immediate Track)

NIH GUDID Devices

Device IDPMASupp
06438147321322 P970037 000
06438147321315 P970037 000

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.